FILE:ALXN/ALXN-8K-20051214114730.txt.gz
EVENTS:	Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
TEXT:
ITEM: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions ( General Instruction A.2. below):
see
 
 
 
 
Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year End.
 
On December 9, 2005, the board of directors of Alexion Pharmaceuticals, Inc. (the "Company") pursuant to the Company's Amended and Restated Bylaws unanimously approved a change in the Company's fiscal year end from July 31 to December 31. The Company intends to file a transition report on Form 10-K covering the five months period from August 1, 2005 to December 31, 2005 within 60 days of December 31, 2005.
 
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
 


